Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene

Carcinogenesis

Volumn 28, Issue 3, 2007, Pages 724-731

  Queille, Sophie ^a   Luron, Lionel ^a   Spatz, Alain ^a   Avril, Marie Françoise ^a,c   Ribrag, Vincent ^a   Duvillard, Pierre ^a   Hiesse, Christian ^b   Sarasin, Alain ^a   Armand, Jean Pierre ^a   Daya Grosjean, Leela ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b BICÊTRE HOSPITAL   (France)

^c Kremlin Bicêtre Hospital ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYSTEINE; PREDNISONE ACETATE; PROTEIN P53; THREONINE; VIRUS DNA; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA REPAIR; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CODON; DNA, VIRAL; GENES, P53; GENOTYPE; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; POLYMORPHISM, GENETIC; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 34047118665     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl191     Document Type: Article

References (58)

1. Euvrard,S., Kanitakis,J. and Claudy,A. (2003) Skin cancers after organ transplantation. N. Engl. J. Med., 348, 1681-1691.
2. Hiesse,C., Kriaa,F., Rieu,P., Larue,J., Benoit,G., Bellamy,J., Blanchet,P. and Charpentier,B. (1995) Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: Analysis of a 20-year period in 1600 patients. Transplant Proc., 27, 972-974.
3. McGregor,J. and Proby,C. (1995) Skin cancer in transplant recipients [letter; comment]. Lancet, 346, 964-965.
4. London,N., Farmery,S., Will,E., Davison,A. and Lodge,J. Risk of neoplasia in renal transplant patients [published erratum appears in Lancet 1995 Sep 9;346(8976): 714] [see comments]. Lancet, 346, 403-406.
5. Andre,N., Roquelaure,B. and Conrath,J. (2004) Molecular effects of cyclosporine and oncogenesis: A new model. Med. Hypotheses, 63, 647-652.
6. Yarosh,D., Canning,M., Teicher,D. and Brown,D. (2005) After sun reversal of DNA damage: Enhancing skin repair. Mutat. Res., 571, 57-64.
7. Lennard,L., Thomas,S., Harrington,C. and Maddocks,J. (1985) Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. Br. J. Dermatol., 113, 723-729.
8. Swann,P., Waters,T., Moulton,D., Xu,Y., Zheng,Q., Edwards,M. and Mace,R. (1996) Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science, 273, 1109-1011.
9. Yarosh,D., Pena,A., Nay,S., Canning,M. and Brown,D. (2005) Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J. Invest. Dermatol., 125, 1020-1025.
10. Hojo,M., Morimoto,T., Maluccio,M., Asano,T., Morimoto,K., Lagman,M., Shimbo,T. and Suthanthiran,M. (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature, 397, 530-534.
11. O'Donovan,P., Perrett,C., Zhang,X., Montaner,B., Xu,Y., Harwood,C., McGregor,J.M, Walker,S., Hanaoka,F. and Karran,P. (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science, 309, 1871-1874.
12. Brash,D., Rudolph,J., Simon,J., Lin,A., McKenna,G., Baden,H., Halperin,A. and Ponten,J. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 88, 10124-10128.
13. Daya-Grosjean,L., Dumaz,N. and Sarasin,A. (1995) The specificity of p53 mutation spectra in sunlight induced human cancers. J. Photochem. Photobiol. B, 28, 115-124.
14. Ziegler,A., Jonason,A., Leffell,D., Simon,J., Sharma,H., Kimmelman,J., Remington,L., Jacks,T. and Brash,D. (1994) Sunburn and p53 in the onset of skin cancer [see comments]. Nature, 372, 773-776.
15. McGregor,J., Berkhout,R., Rozycka,M., ter Schegget,J., Bouwes,B.J., Brooks,L. and Crook,T. (1997) p53 mutations implicate sunlight in posttransplant skin cancer irrespective of human papillomavirus status. Oncogene, 15, 1737-1740.
16. McGregor,J.M., Harwood,C.A., Brooks,L. et al. (2002) Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J. Invest. Dermatol., 119, 84-90.
17. Stark,L., Arends,M., McLaren,K., Benton,E., Shahidullah,H., Hunter,J. and Bird,C. (1994) Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients. Br. J. Cancer, 70, 662-667.
18. Khorshid,S., Glover,M., Churchill,L., McGregor,J. and Proby,C. (1996) p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: A comparative study of 246 tumours. J. Cutan. Pathol., 23, 229-233.
19. Blokx,W., de Jong,E., de Wilde,P., Bulten,J., Link,M., Ruiter,D. and van de Kerkhof,P. (2003) P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Mod. Pathol., 16, 869-878.
20. O'Connor,D., Kay,E., Leader,M., Murphy,G., Atkins,G. and Mabruk,M.J. (2001) Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: Correlation with human papillomaviruses? Diagn. Mol. Pathol., 10, 190-199.
21. Euvrard,S., Chardonnet,Y., Pouteil-Noble,C., Kanitakis,J., Chignol,M., Thivolet,J. and Touraine,J. (1993) Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer, 72, 2198-2206.
22. Berkhout,R.J., Tieben,L.M., Smits,H.L., Bavinck,J.N., Vermeer,B.J. and ter Schegget,J. (1995) Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J. Clin. Microbiol., 33, 690-695.
23. Shamanin,V., Glover,M., Rausch,C., Proby,C., Leigh,I., zur Hausen,H. and de Villiers,E. (1994) Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res., 54, 4610-4613.
24. Storey,A., Thomas,M., Kalita,A., Harwood,C., Gardiol,D., Mantovani,F., Breuer,J., Leigh,I., Matlashewski,G. and Banks,L. (1998) Role of a p53 polymorphism in the development of human papillomavirus- associated cancer [see comments]. Nature, 393, 229-234.
25. O'Connor,D.P., Kay,E.W., Leader,M., Atkins,G.J., Murphy,G.M. and Mabruk,M.J. (2001) p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J. Clin. Pathol., 54, 539-542.
26. Marshall,S., Bordea,C., Wojnarowska,F., Morris,P. and Welsh,K. (2000) p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. Transplantation, 69, 994-996.
27. Shen,M.R., Jones,I.M. and Mohrenweiser,H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58, 604-648.
28. Benhamou,S. and Sarasin,A. (2002) ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis, 17, 463-469.
29. Benhamou,S. and Sarasin,A. (2005) ERCC2/XPD gene polymorphisms and lung cancer: A HuGE review. Am. J. Epidemiol., 161, 1-14.
30. Dumaz,N., Duthu,A., Ehrhart,J., Drougard,C., Appella,E., Anderson,C., May,P., Sarasin,A. and Daya-Grosjean,L. (1997) Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes. Mol. Carcinog., 20, 340-347.
31. Harwood,C., Spink,P., Surentheran,T., Leigh,I., de Villiers,E., McGregor,J., Proby,C. and Breuer,J. (1999) Degenerate and nested PCR: A highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J. Clin. Microbiol., 37, 3545-3555.
32. Shamanin,V., Delius,H. and de Villiers,E. (1994) Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J. Gen. Virol., 75, 1149-1156.
33. Manos,M.M., Ting,Y., Wright,D.K., Lewis,A.J., Broker,T.R. and Molinsky,S.M. (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7, 209-214.
34. Snijders,P., van den Brule,A., Schrijnemakers,H., Snow,G., Meijer,C. and Walboomers,J. (1990) The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J. Gen. Virol., 71, 173-181.
35. Norris,P., Limb,G., Hamblin,A. and Hawk,J. (1988) Impairment of natural-killer-cell activity in xeroderma pigmentosum. N. Engl. J. Med., 319, 1668-1669.
36. Gaspari,A., Fleisher,T. and Kraemer,K. (1993) Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J. Clin. Invest., 92, 1135-1142.
37. Suzuki,H., Kalair,W., Shivji,G.M., Wang,B., Toto,P., Amerio,P., Kraemer,K.H. and Sauder,D.N. (2001) Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts. J. Invest. Dermatol., 117, 1151-1155.
38. Daya-Grosjean,L. and Sarasin,A. (2005) The role of UV induced lesions in skin carcinogenesis: An overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat. Res., 571, 43-56.
39. Purdie,K.J., Surentheran,T., Sterling,J.C., Bell,L., McGregor,J.M., Proby,C.M., Harwood,C.A. and Breuer,J. (2005) Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J. Invest. Dermatol., 125, 98-107.
40. Schaper,I., Marcuzzi,G., Weissenborn,S., Kasper,H., Dries,V., Smyth,N., Fuchs,P. and Pfister,H. (2005) Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res., 65, 1394-1400.
41. Giampieri,S., Garcia-Escudero,R., Green,J. and Storey,A. (2004) Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. Oncogene, 23, 5864-5870.
42. Jackson,S. and Storey,A. (2000) E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene, 19, 592-598.
43. Akgul,B., Garcia-Escudero,R., Ghali,L., Pfister,H., Fuchs,P., Navsaria,H. and Storey,A. (2005) The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res., 65, 2216-2223.
44. Purdie,K., Pennington,J., Proby,C., Khalaf,S., de Villiers,E., Leigh,I. and Storey,A. (1999) The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J., 18, 5359-5369.
45. Cheng,K., Cahill,D., Kasai,H., Nishimura,S. and Loeb,L. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G - T and A - C substitutions. J. Biol. Chem., 267, 166-172.
46. Kvam,E. and Tyrrell,R. (1997) Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis, 18, 2379-2384.
47. Agar,N., Halliday,G., Barnetson,R., Ananthaswamy,H., Wheeler,M. and Jones,A. (2004) The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: A role for UVA in human skin carcinogenesis. Proc. Natl Acad. Sci. USA, 101, 4954-4959.
48. Halliday,G. (2005) Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat. Res., 571, 107-120.
49. Vu,B., Cannistraro,V., Sun,L. and Taylor,J. (2006) DNA synthesis past a 5-methylC-containing cis-syn-cyclobutane pyrimidine dimer by yeast pol eta is highly nonmutagenic. Biochemistry, 45, 9327-9335.
50. Lee,D. and Pfeifer,G. (2003) Deamination of 5-methylcytosines within cyclobutane pyrimidine dimers is an important component of UVB mutagenesis. J. Biol. Chem., 278, 10314-10321.
51. Kelly,G., Meikle,W. and Sheil,A. (1987) Scheduled and unscheduled DNA synthesis in epidermal cells of hairless mice treated with immunosuppressive drugs and UVB-UVA irradiation. Br. J. Dermatol., 117, 429-440.
52. Sugie,N., Fujii,N. and Danno,K. (2002) Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation. Photodermatol. Photoimmunol. Photomed., 18, 163-8.
53. Dumaz,N., Drougard,C., Sarasin,A. and Daya-Grosjean,L. (1993) Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc. Natl Acad. Sci. USA, 90, 10529-10533.
54. Giglia,G., Dumaz,N., Drougard,C., Avril,M., Daya-Grosjean,L. and Sarasin,A. (1998) p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group,C. Cancer Res., 58, 4402-4409.
55. Giglia-Mari,G. and Sarasin,A. (2003) TP53 mutations in human skin cancers. Hum. Mutat., 21, 217-228.
56. Vogel,U., Wallin,H., Overvad,K., Tjonneland,A. and Nexo,B. (2005) Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucassians after age 50. Cancer Detect. Prev., 29, 209-214.
57. Vogel,U., Hedayati,M., Dybdahl,M., Grossman,L. and Nexo,B.A. (2001) Polymorphisms of the DNA repair gene XPD: Correlations with risk of basal cell carcinoma revisited. Carcinogenesis, 22, 899-904.
58. Dybdahl,M., Vogel,U., Frentz,G., Wallin,H. and Nexo,B.A. (1999) Polymorphisms in the DNA repair gene XPD: Correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 8, 77-81.